Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05286827
Title Phase II Study of Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

pancreatic acinar cell adenocarcinoma

Therapies

Olaparib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.